The targeted sequencing market was estimated to be worth USD 3.6 billion globally in 2022, and over the course of the projected period, a CAGR of 12.3% is anticipated. The targeted sequencing market is expanding because to a rise in research projects and a growing need for early illness identification. Pharmacogenomics, uncommon disease detection, and genetic variant identification for crop development, increased agricultural output, and breeding programs all benefit greatly from it. Using material blood samples, it is also utilized to find genetic problems in fetuses.
Technological developments in sequencing are driving down sequencing prices and driving up usage in research and therapeutic contexts. The need for targeted sequencing is being driven by the rising incidence of genetic diseases. The global expansion of research and development endeavors is propelling the market's growth.

Request For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/targeted-sequencing-market

Growth Drivers
The market is expected to increase significantly due to ongoing advancements in sequencing technologies, growing acceptance in clinical and research settings, and the expanding applications of genomics across numerous industries. The market is growing at a substantial rate due to the significance of genomics in public health response and preparation. The efficiency, accuracy, and cost-effectiveness of next-generation sequencing technology have all increased due to ongoing developments. Its enhanced depth and precision in high-throughput sequencing of targeted genomic areas encourages its use in clinical and scientific applications.
The demand for targeted sequencing is being driven by the increased emphasis on customized medicine, which entails customizing medical care to each patient's unique genetic traits. It facilitates the development of tailored medicines by allowing the detection of genetic variation linked to disease, drug responses, and treatment results. The market is expanding dramatically because to the rising incidence of genetic disorders, auto-immune diseases, and cancer.
Segmentation
Product Type
· Instruments
· Services
· Kits/ Panels
· Others
By End-User
· Diagnostic and Clinical Laboratories
· Academic and Research Institutions
· Pharmaceutical and Biotech Companies
· Others
By Application
· Cancer
· Reproductive Health
· Heredity Diseases
· Neurological Disorders
· Infectious Diseases
· Rare Diseases
· Cardiovascular Diseases
· Others
Regional Outlook
· Asia Pacific
· North America
· Latin America
· Europe
· Middle East and Africa
Key Players
· Illumina
· Thermo Fisher Scientific
· Qiagen
· Agilent Technologies
· BGI Group
· Roche
· Oxford Nanopore Technologies
· Pacific Biosciences
· PerkinElmer
· GenScript
· Other Players
For More Information about this Report @ https://www.xresearch.biz/shop/targeted-sequencing-market

About Us: -
xResearch is a market research and consulting organization that uses unique data, expert analysis, and new technologies to create trusted intelligence on industries. Our research is focused on delivering an informed and impartial view on essential market data of industry, and it is primarily driven by an in-depth study covering the following parameters: Market Sizing and Forecasting, Market Segmentation, Competitive Analysis, Strategic Assessment and Business Modelling.

Contact:
Company Name: xResearch
Contact Person: James Lin
Email: [email protected]
Phone: +1 718-618-4545